Financial reports
10-K
2023 FY
Annual report
20 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
5 May 23
ARS
2022 FY
Annual report to shareholders
20 Apr 23
10-K
2022 FY
Annual report
16 Feb 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
26 Apr 22
10-K
2021 FY
Annual report
25 Feb 22
Current reports
8-K
Other Events
5 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 23
8-K
Other Events
6 Jan 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 22
8-K
Entry into a Material Definitive Agreement
8 Jun 21
8-K
Departure of Directors or Certain Officers
4 Jan 21
8-K
Submission of Matters to a Vote of Security Holders
21 Dec 20
8-K
Unregistered Sales of Equity Securities
14 Oct 20
8-K
Material Modifications to Rights of Security Holders
23 Sep 20
8-K
Enzon Pharmaceuticals Announces Key Dates for Rights Offering
15 Sep 20
Registration and prospectus
8-A12G/A
Registration of securities (amended)
8 Jun 21
424B3
Prospectus supplement
24 Nov 20
S-1
IPO registration
12 Nov 20
424B3
Prospectus supplement
23 Sep 20
S-1/A
IPO registration (amended)
15 Sep 20
S-1
IPO registration
1 Sep 20
8-A12G
Registration of securities
14 Aug 20
15-12G
Securities registration termination
13 Feb 18
25-NSE
Exchange delisting
10 Jun 16
8-A12B
Registration of securities on exchange
1 May 14
Proxies
DEFA14A
Additional proxy soliciting materials
20 Apr 23
DEF 14A
Definitive proxy
20 Apr 23
DEFA14A
Additional proxy soliciting materials
22 Apr 22
DEF 14A
Definitive proxy
22 Apr 22
DEFA14A
Additional proxy soliciting materials
14 Apr 21
DEF 14A
Definitive proxy
14 Apr 21
PRE 14A
Preliminary proxy
2 Apr 21
DEFA14A
Additional proxy soliciting materials
3 Nov 20
DEF 14A
Definitive proxy
3 Nov 20
DEFA14A
Additional proxy soliciting materials
12 Jul 19
Other
EFFECT
Notice of effectiveness
24 Nov 20
CORRESP
Correspondence with SEC
18 Nov 20
UPLOAD
Letter from SEC
17 Nov 20
EFFECT
Notice of effectiveness
22 Sep 20
CORRESP
Correspondence with SEC
17 Sep 20
UPLOAD
Letter from SEC
8 Sep 20
UPLOAD
Letter from SEC
12 Oct 12
CORRESP
Correspondence with SEC
20 Sep 12
UPLOAD
Letter from SEC
7 Sep 12
CORRESP
Correspondence with SEC
13 Aug 12
Ownership
4
RANDOLPH C READ
16 Jun 23
3
Jaffrey Adam Firestone
21 Jun 22
4
JONATHAN COUCHMAN
17 Aug 21
4
RANDOLPH C READ
18 Nov 20
4
Jordan Bleznick
17 Nov 20
4
CARL C ICAHN
14 Oct 20
SC 13D/A
ICAHN CARL C
14 Oct 20
SC 13D/A
COUCHMAN JONATHAN
17 Sep 20
SC 13D/A
ICAHN CARL C
1 Sep 20
4
JONATHAN COUCHMAN
26 Aug 20